SCHEMBL29365356

SCHEMBL29365356

COc1ccc(-c2ccc(C(=O)O)cc2)cn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.73
MKNK2 Q9HBH9 2/20 0.73
NNMT P40261 1/20 0.57
OXTR P30559 1/20 0.56
PDGFRB P09619 1/20 0.55
PDGFRA P16234 1/20 0.55
HSD17B1 P14061 1/20 0.54
HSD17B2 P37059 1/20 0.54
RXRA P19793 1/20 0.53
MAP4K4 O95819 2/20 0.52
MAPT P10636 1/20 0.51
CYP2A6 P11509 1/20 0.50
HDAC3 O15379 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
CD274 Q9NZQ7 1/20 0.49
EGLN1 Q9GZT9 1/20 0.49
CHEK1 O14757 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
TAS2R14 Q9NYV8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1870306 1.00 MKNK1 (0.73) MKNK1MKNK2NNMTOXTRPDGFRB
SCHEMBL30280631 0.86 MKNK1 (0.73) MKNK1MKNK2NNMTOXTRPDGFRB
SCHEMBL12641872 0.86 MKNK1 (0.73) MKNK1MKNK2NNMTOXTRPDGFRB
SCHEMBL29757598 0.85 NNMT (0.70) MKNK1MKNK2NNMTOXTRMAPT
SCHEMBL185291 0.85 NNMT (0.70) MKNK1MKNK2NNMTOXTRMAPT
SCHEMBL1869662 0.85 MKNK1 (0.59) MKNK1MKNK2NNMTOXTRMAPT
SCHEMBL2945799 0.85 MKNK1 (0.71) MKNK1MKNK2NNMTOXTRHSD17B1
SCHEMBL2224592 0.84 MAP4K4 (0.77) MKNK1MKNK2MAP4K4
SCHEMBL703607 0.84 NNMT (0.68) MKNK1MKNK2NNMTOXTRMAPT
SCHEMBL2039201 0.83 MAPT (0.76) MKNK1MKNK2PDGFRBPDGFRARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114773249-B Compounds, pharmaceutical compositions and methods for treating inflammatory diseases 艾匹克治疗公司 2024-08-16 CN disclosed
CN-113980001-B Pyrazolol-pyridazinone coupling compound, pharmaceutical composition thereof and application of pyrazolol-pyridazinone coupling compound in medicines 贵州医科大学 2024-01-30 CN disclosed
CN-114773249-A Compounds, pharmaceutical compositions and methods for treating inflammatory diseases 艾匹克治疗公司 2022-07-22 CN disclosed
CN-113980001-A Pyrazole alcohol-pyridazinone coupling compound, pharmaceutical composition thereof and application thereof in medicines 贵州医科大学 2022-01-28 CN disclosed